CarMax Earnings Crash on Comparable Sales
CarMax reported disappointing fiscal third-quarter financial results before the markets opened on Friday.
All Work
Chris Lange
Why Micron May Have 5 Times More Upside Than Downside
Despite having a dismal year, Micron Technology might be turning things around with its most recent acquisition.
Intercept Pharma Disappoints on FDA Extension
Intercept Pharmaceuticals announced that the FDA has extended the PDUFA date for its Priority Review of obeticholic acid in primary biliary cholangitis.
How BlackBerry Stunned Investors with Q3 Earnings
BlackBerry reported better-than-expected fiscal third-quarter financial results before the markets opened on Friday.
Red Hat Continues to Rally on Solid Earnings
Red Hat reported its fiscal third-quarter financial results after the markets closed on Thursday.
What to Expect From BlackBerry Earnings
BlackBerry is scheduled to report its fiscal third-quarter financial results before the markets open on Friday.
SEC Charges Hedge Fund Manager Martin Shkreli With Fraud
The SEC has charged Martin Shkreli, former CEO of pharmaceutical company Retrophin, with committing fraud during a five-year period when he also was working as a hedge fund manager.
SEC Bars Hedge Fund Manager for Misleading Investors
The SEC barred hedge fund adviser Owen Li from the securities industry for making a series of false statements to investors and ultimately precipitating a fund's collapse.
Pandora Wins on Copyright Royalty Board Rates
Pandora Media saw its shares shoot up early Thursday,following the announcement by the Copyright Royalty Board regarding the rates online streamers might pay for content.
Pier 1 Collapses on Guidance
Pier 1 Imports reported mixed fiscal third-quarter financial results Thursday after the markets closed on Wednesday.
Bicapital Updates Finances in Most Recent IPO Filing
In its latest SEC filing concerning its IPO, Guatemalan financial services provider Bicapital described its finances.
Martin Shkreli Stocks Turn Toxic Upon Arrest
As quickly as KaloBios Pharmaceuticals shares shot up, they are dropping after its newly named chief executive, Martin Shkreli, was arrested.
Are Oracle Results Enough for Investors?
Oracle reported better-than-expected fiscal second-quarter financial results after the markets closed on Wednesday.
SEC Charges New Jersey Firm in Pump-and-Dump Scheme
The SEC has issued charges against a New Jersey man and his company in regard to illicitly pocketing $13 million from an elaborate pump-and-dump scheme.
What to Expect From Rite Aid Earnings
Rite Aid is scheduled to report its fiscal third-quarter financial results before the markets open on Thursday.
Is Global Payments Paying Too Much for Heartland?
Global Payments has announced that it has entered into a definitive agreement to acquire Heartland Payment for $100 per share, or approximately $4.3 billion.
SEC Issues Fraud Charges Over Native American Bonds
Atlantic Asset Management stands accused of investing clients in certain bonds with a hidden financial benefit to a broker-dealer connected to the firm.
Bats Global Markets Files for IPO
Bats Global Markets has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
CyberArk Beats Out Peers for Homeland Security Award
CyberArk Software announced that it was named a winner in the 2015 GSN Homeland Security Awards in two categories.
Advaxis Skyrockets on Resumed Clinical Trials
Advaxis has announced that the FDA has lifted the clinical hold on all of its Investigational New Drug (IND) applications for its three product candidates